Aims and Scope
According to World Health Organization estimates, diabetes deaths are projected to double between 2005 and 2030, and 5% of deaths worldwide can already be attributed to the disease. Effective treatment and, ideally, prevention are therefore vital goals in dealing with this global epidemic.
Diabetes Management presents findings, analysis and commentary on the battle with Type I and Type II diabetes. Articles published in Diabetes Management address improvements in current therapeutics and patient compliance together with perspectives on future prospects. Coverage focuses on the key objective of stabilizing blood glucose levels in individuals with either form of the disease, and the associated issues of patient co operation and education. The journal also reflects the frontiers of current research, such as attempts to recreate pancreatic cells through stem cell technology or islet cell transplantation, the development of a vaccine for Type 1 disease and the potential for biomarkers to be used for the detection. The increasing understanding of the molecular basis of the disease and associated genetics will play an important part in future diabetes management.
Prevention of diabetes is a key issue. Diabetes Management discusses the impact of encouraging healthier lifestyles to reduce the risk of Type 2 diabetes and importance of education in this context and with respect to symptoms.
Diabetes Management provides clinicians with the latest findings and opinions on the optimum therapies for reducing the disabling effects of uncontrolled diabetes. Recent research findings and advances clinical practice in the field are reported and analyzed by international experts.
Topics covered include:
- Techniques in monitoring blood glucose
- Methods of stabilizing diabetes
- Tailoring nutrition and lifestyle to control diabetes
- Appropriate therapy for all groups including pediatric, geriatric and pregnant patients
- Analysis of success and failure in the latest diabetic medication, including compliance
- Management of diabetic neuropathy, retinopathy and other consequences of poorly managed diabetes
- Recent advances in research to recreate pancreatic cells: immunological considerations and regenerative techniques
- Role of autoimmunity in the development of Type I diabetes
- Tackling mental health problems that develop as a result of the disease
- Epidemiologic and genetic studies
- Pharmacoeconomics and outcomes
Articles are subject to peer-review by three independent referees on a double-blind basis. Authors publishing in the journal are asked to disclose any professional or financial interest that may be perceived as causing a conflict of interest in the context of the article.
The journal welcomes unsolicited article proposals.
Indexed in: Chemical Abstracts; EMBASE/Excerpta Medica; EMCare
Current Volume: This journal has ceased publication
Issues per Year: 6
Average Abstract Views: 1,777 (January 2015 - December 2015)
Open Access Option: For all article types except for Drug or Device Evaluations
Average Lead Time to Online Publication: 14 - 16 weeks
Rapid Publication Option: Yes